AMR101: Completed Phase III enrollment

Amarin completed enrollment of 229 patients with fasting triglyceride levels of >=500 mg/dL in the double-blind, placebo-controlled Phase III MARINE trial. The study is evaluating 2 and 4 g of oral AM...